| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.002 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.002 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.003 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.006 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.006 |